menu ☰
menu ˟

Cutaneous Eruption due to Telaprevir

28 Sep 2015

Hepatitis C virus (HCV) chronically infects 0.5-3% of the world population. A large group of patients develop cirrhosis and its complications. Since 2011, telaprevir and boceprevir are used, improving the disease evolution. One of the main side effects of these drugs is skin eruption. We report a 53-year-old patient with cirrhosis due to HCV who started the classic treatment associated with telaprevir. In the ninth week, he presented a severe rash that required the interruption of this drug. We emphasize the importance of early recognition and appropriate management of adverse skin reaction.
Case Rep Dermatol 2015;7:253-262

Click here to view the full article which appeared in Case Reports in Dermatology